Johnson & Johnson News on Daylife

INSURANCE FOR UNHEALTHY AMERICANS

Tue, 08 Dec 2009 19:31:09 GMT

and the American Diabetes Association are against the measure on the grounds it discriminates against people who want to stay fat and won't quit smoking.
Source: Lowell Sun Online

J&J files injectable once-monthly Invega in EU for schizophrenia

Tue, 08 Dec 2009 17:05:03 GMT

Today Katie McQue Please Login to read the full article.
Source: Scrip News

Eargasms

Tue, 08 Dec 2009 14:31:55 GMT

Probably one of BEST feelings in the world is an. Seriously. I should own stock in Johnson & Johnson Q-tips. I can easily use at least 10 Q-tips a day. This is one of those tiny quirky things about me. And it's contagious.....
Source: Associated Content

Goldman, Apple -- The Big Tells?

Tue, 08 Dec 2009 13:49:11 GMT

Remember when the mantra was so goes Goldman Sachs (GS - commentary - Trade Now), so goes the market? Then we lost Goldman. But that was OK because we still had Apple (AAPL - commentary - Trade Now). But we lost Apple too.
Source: The Street

Quoted in 'Patent Expiries of Blockbuster Antibiotics Will Fuel a Decline of More Than 15 Percent in the Community-Acquired Pneumonia Drug Market'

Tue, 08 Dec 2009 13:43:40 GMT

said in PR Newswire:

Two of the most clinically and commercially promising antibiotics in late-stage development are Johnson & Johnson/Basilea's ceftobiprole and Forest Laboratories/AstraZeneca/Takeda's ceftaroline, which are both broad-spectrum intravenous agents with anti-MRSA activity ... We forecast that these two agents combined will earn nearly $100 million in the community-acquired pneumonia market in 2018.

Patent Expiries of Blockbuster Antibiotics Will Fuel a Decline of More Than 15 Percent in the Community-Acquired Pneumonia Drug Market

Tue, 08 Dec 2009 13:43:40 GMT

WALTHAM, Mass. , Dec. 8 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the patent expiries of three blockbuster antibiotics -- levofloxacin, moxifloxacin...
Source: PR Newswire

TNS Media Intelligence Reports U.S. Advertising Expenditures Declined 14.7 Percent in First Nine Months of 2009

Tue, 08 Dec 2009 12:38:22 GMT

December 8, 2009 7:30 AM EST Percent Change in Measured Ad Spending: Jan-Sept 2009 vs. Jan-Sept 20081 MEDIA SECTOR % CHANGE -- Media Type (Sectors and types listed in rank order of spending) TELEVISION MEDIA -12.1% -- Network TV -11.
Source: Street Insider

Research and Markets: Johnson & Johnson: Performance, Capabilities, Goals and Strategies in the Worldwide Orthopedics Market ..

Tue, 08 Dec 2009 12:03:41 GMT

Disclaimer: (c) 2009 Business Wire. All of the news releases contained herein are protected by copyright and other applicable laws, treaties and conventions.
Source: PR-Inside.com

Ethicon wins ruling in patent case

Tue, 08 Dec 2009 10:46:27 GMT

Johnson & Johnson's Ethicon Endo-Surgery unit convinced a federal appeals court that it didn't infringe Covidien PLC's Tyco Healthcare Group patents because Tyco was unable to prove ownership of the technology.
Source: Cincinnati Enquirer

Quoted in 'The Motley Fool's Weekly Editors' Picks'

Sat, 05 Dec 2009 13:34:52 GMT

said in Motley Fool:

If soaring financials like Bank of America (NYSE: BAC) and Wells Fargo (NYSE: WFC) have increased the risk level of your portfolio … consider diversifying into blue chips in other sectors such as PepsiCo (NYSE: PEP) and Johnson & Johnson (NYSE: JNJ).

Photo from AP Photo

Tue, 14 Jul 2009 15:02:41 GMT

A box of Johnson & Johnson BAND-AID bandages is shown, Tuesday, July 14, 2009, in Boston.

Photo from AP Photo

Mon, 25 May 2009 15:44:06 GMT

This undtaed handout photo provided by Johnson & Johnson shows an IBOT wheelchair.

Cotonetes Johnson & Johnson - "Banheira"- 1978

Tue, 01 Apr 2008 14:46:03 GMT